Misoprostol Before Caesarean Section
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorKafrelsheikh University
About this trial
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Eligibility criteria
Qualifiers
Women with indication for elective caesarean section.
Age less than 35 years old.
Gestational age less than 38 weeks.
Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
Disqualifiers
Any obstetric disorders as preeclampsia and diabetes.
Fetus with oligohydramnios, intrauterine growth restriction.
Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.
History of more than or equal 2 previous caesarean section.
Trial design
Treatments tested in this trial
- Misoprostol
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov